Valuation: Granules India Limited

Capitalization 143B 1.56B 1.34B 1.21B 1.16B 2.12B 2.22B 14.31B 5.73B 68.54B 5.84B 5.71B 245B P/E ratio 2026 *
23.2x
P/E ratio 2027 * 19x
Enterprise value 148B 1.61B 1.39B 1.25B 1.2B 2.19B 2.29B 14.79B 5.92B 70.83B 6.03B 5.9B 253B EV / Sales 2026 *
2.78x
EV / Sales 2027 * 2.37x
Free-Float
56.35%
Yield 2026 *
0.23%
Yield 2027 * 0.23%
1 day+0.52%
1 week-0.83%
Current month-0.83%
1 month+2.22%
3 months+2.88%
6 months+12.89%
Current year-3.63%
1 week 520.05
Extreme 520.05
587.15
1 month 520.05
Extreme 520.05
606.4
Current year 520.05
Extreme 520.05
627.45
1 year 412.05
Extreme 412.05
627.45
3 years 267.85
Extreme 267.85
724.55
5 years 227
Extreme 227
724.55
10 years 71.75
Extreme 71.75
724.55
Manager TitleAgeSince
Chief Executive Officer 71 2025-07-30
Director of Finance/CFO 46 2022-12-29
President - 2023-08-31
Director TitleAgeSince
Chairman 71 2013-08-20
Director/Board Member 42 2004-12-31
Director/Board Member 66 2012-05-30
Change 5d. change 1-year change 3-years change Capi.($)
+0.52%-0.83%+16.97%+99.21% 1.56B
+0.72%-5.86%+8.50%+210.49% 885B
+0.32%-3.23%+44.97%+54.54% 579B
-0.96%-0.85%+9.19%+48.19% 407B
-2.93%-7.03%+12.72%+26.04% 350B
-1.25%-5.55%+23.92%+55.59% 302B
-1.85%-6.70%+20.55%+34.98% 301B
-0.24%-6.49%+23.18%+4.22% 286B
+0.53%-4.80%+16.27%+57.17% 199B
-0.83%-3.37%+24.03%+77.45% 179B
Average -0.60%-4.31%+20.03%+66.79% 349.03B
Weighted average by Cap. -0.47%-4.59%+19.88%+86.09%

Financials

2026 *2027 *
Net sales 53.05B 577M 498M 449M 431M 786M 823M 5.31B 2.13B 25.44B 2.17B 2.12B 90.99B 61.63B 671M 578M 522M 501M 913M 956M 6.17B 2.47B 29.55B 2.52B 2.46B 106B
Net income 5.91B 64.32M 55.46M 50.06M 48.04M 87.6M 91.67M 592M 237M 2.83B 241M 236M 10.14B 7.53B 81.9M 70.62M 63.75M 61.17M 112M 117M 754M 302M 3.61B 307M 301M 12.91B
Net Debt 4.77B 51.88M 44.73M 40.38M 38.75M 70.65M 73.94M 477M 191M 2.29B 195M 191M 8.18B 3.17B 34.53M 29.77M 26.87M 25.78M 47.02M 49.21M 318M 127M 1.52B 130M 127M 5.44B
Logo Granules India Limited
Granules India Limited is an India-based pharmaceutical manufacturing company. The Company operates through its pharmaceutical’s products segment. Its geographical segments include within India and outside India. The Company has its presence across the pharmaceutical manufacturing value chain, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs) and finished dosages (FDs). It produces and supplies Paracetamol, Metformin, Guaifenesin, and Methocarbamol APIs. It has over seven manufacturing facilities, approximately six of which are located in India and one in the United States. The Company sells its products in the global markets, including the United States of America, Canada, Latin America, Europe, Asia Pacific, and India. The Company’s wholly owned subsidiaries include Granules USA Inc, Granules Pharmaceuticals Inc, Granules Europe Limited and Granules Lifesciences Private Limited.
Employees
4,066
Date Price Change Volume
26-03-06 576.80 +0.52% 25,584
26-03-05 573.80 +3.67% 27,870
26-03-04 553.50 -3.66% 70,691
26-03-02 574.55 -1.22% 12,369
26-02-27 581.65 -1.47% 22,213
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
576.80INR
Average target price
654.86INR
Spread / Average Target
+13.53%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. GRANULES Stock